Tovinontrine
Sponsors
Cardurion Pharmaceuticals Inc.
Conditions
Heart failure (HF) with reduced ejection fraction (HFrEF)chronic heart failure
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction
CompletedCTIS2023-508736-62-00
Start: 2024-08-08End: 2025-10-10Target: 265Updated: 2025-06-11
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction
CompletedCTIS2023-508737-13-00
Start: 2024-08-08End: 2025-08-29Target: 128Updated: 2025-06-12